Overview
Mohamed Mohamed is a Hematologist and an Oncologist in Greensboro, North Carolina. Dr. Mohamed is rated as an Experienced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and EGFR Positive Lung Cancer. Dr. Mohamed is currently accepting new patients.
His clinical research consists of co-authoring 3 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
501 N Elam Ave, Greensboro, NC 27403
1200 N Elm St, Greensboro, NC 27401
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Duke Blood Cancer Center
An interest in biological sciences and giving back to the community drove me to medical school, but it has been a desire to advance the field of hematologic malignancies, specifically Multiple Myeloma, that brings me to Duke Health. Cancer is a life-altering diagnosis. With a strong, competent team caring for a patient, there can be many success stories. My goal is to empower my patients to understand their diagnosis and how to manage their disease while providing them with many treatment options along the way. Dr. Costa is rated as an Advanced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Hereditary Cerebral Amyloid Angiopathy, and Bone Marrow Aspiration.
Patricia Zekan is an Oncologist and a Hematologist Oncology provider in Winston Salem, North Carolina. Dr. Zekan is rated as an Advanced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Paget Disease of the Breast, Multiple Myeloma, and Schnitzler Syndrome. Dr. Zekan is currently accepting new patients.
Novant Health Thomasville Medical Center LLC
Kathleen Elliott is a Hematologist and a Transplant Surgeon in Thomasville, North Carolina. Dr. Elliott is rated as an Advanced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. Her top areas of expertise are Non-Hodgkin Lymphoma, Hairy Cell Leukemia (HCL), Leukocytosis, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Elliott is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Mohamed isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Mohamed isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Mohamed isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Mohamed isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Mohamed isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Mohamed isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Clear Cell SarcomaDr. Mohamed isAdvanced. Learn about Clear Cell Sarcoma.
- Hodgkin LymphomaDr. Mohamed isAdvanced. Learn about Hodgkin Lymphoma.
- MelanomaDr. Mohamed isAdvanced. Learn about Melanoma.
- Neuroendocrine TumorDr. Mohamed isAdvanced. Learn about Neuroendocrine Tumor.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Paget Disease of the BreastDr. Mohamed isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Mohamed isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Adult Immune ThrombocytopeniaDr. Mohamed isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Mohamed isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Mohamed isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Mohamed isExperienced. Learn about Anemia.
- AngiosarcomaDr. Mohamed isExperienced. Learn about Angiosarcoma.